[Depakine: 25 years in Russia].  The article summarizes domestic and international studies on the development and clinical investigation of valproates including multiple studies of a research team directed by the author.
Valproate targets are considered in biological and clinical aspects.  A spectrum of action and advantages of the brand drug (depakine) compared to generics and other antiepileptic drugs are discussed.
A number of recommendations for practitioners about using valproates are proposed.
